Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 47, Pages 19077-19082
Publisher
Proceedings of the National Academy of Sciences
Online
2013-11-05
DOI
10.1073/pnas.1314476110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meningococcal X polysaccharide quantification by high-performance anion-exchange chromatography using synthetic N-acetylglucosamine-4-phosphate as standard
- (2013) F. Micoli et al. ANALYTICAL BIOCHEMISTRY
- Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine
- (2013) Ouli Xie et al. VACCINE
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
- (2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant CLINICAL INFECTIOUS DISEASES
- Glycoconjugate vaccines
- (2012) David Pace EXPERT OPINION ON BIOLOGICAL THERAPY
- MenACWY-TT vaccine for active immunization against invasive meningococcal disease
- (2012) Vassiliki Papaevangelou et al. Expert Review of Vaccines
- Quantitative Proton Nuclear Magnetic Resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X
- (2012) Raine Garrido et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- O:2-CRM197 Conjugates against Salmonella Paratyphi A
- (2012) Francesca Micoli et al. PLoS One
- Relative stability of meningococcal serogroup A and X polysaccharides
- (2012) F. Berti et al. VACCINE
- Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies
- (2012) Ouli Xie et al. VACCINE
- Development of a group A meningococcal conjugate vaccine,MenAfriVacTM
- (2012) Carl Frasch et al. Human Vaccines & Immunotherapeutics
- Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications
- (2011) Michael Bröker et al. BIOLOGICALS
- The design of semi-synthetic and synthetic glycoconjugate vaccines
- (2011) Paolo Costantino et al. Expert Opinion on Drug Discovery
- Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
- (2011) Jan Poolman et al. Expert Review of Vaccines
- Meningococcal glycoconjugate vaccines
- (2011) Roberto Gasparini et al. Human vaccines & immunotherapeutics
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
- (2011) Isabelle Delrieu et al. PLoS One
- Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi
- (2011) F. Micoli et al. VACCINE
- Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age
- (2010) Scott A. Halperin et al. VACCINE
- Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution
- (2009) F. Marc LaForce et al. VACCINE
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
- (2008) Martin C. J. Maiden et al. JOURNAL OF INFECTIOUS DISEASES
- Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching
- (2008) H.-K. Guttormsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started